Keywords: schering, ag, starts, ph, ii, zk-epo, trials

Schering AG starts Ph II ZK-EPO trials

Article | 29 May 2006

Print This

German pharmaceutical firm Schering AG has announced the start of two new Phase II clinical trials of ZK-EPO, its novel ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in